Soumyajit Roy (Soum)
@Soum_Roy_RadOnc
Followers
962
Following
14K
Media
91
Statuses
3K
Human, #IMG, #RadOnc via @aiims_newdelhi @RushCancer @EdinburghUni (MSc. biostat-epi). Now @RadOncUH @CASECCC. Editor @Advances_ASTRO. #PCSM #Rstats #research.
Cleveland, OH
Joined February 2016
It wouldn't 've been possible w/out immense support from @jmmrad @WallisCJD @AmarUKishan @HimanshuNagarMD @mishabeltran @NicholasZaorsky @angela_jia_ @aleberlin2 @ASCOPres, Prof Eastham, Prof Gleave, Prof Roach, Prof Sandler, Prof Ponsky, Dr Morgan among many others
2
1
17
๐.๐.๐.๐.๐.๐.๐.๐.๐ ๐ Congratulations to #TeamIndia on winning their maiden ICC Women's Cricket World Cup ๐ฎ๐ณ Take. A. Bow ๐ #WomenInBlue | #CWC25 | #Final | #INDvSA
2K
19K
85K
November is #PancreaticCancer awareness month. Listen to @NiuSanford on how weโre using radiation for unresectable pancreas cancer in one of our newest trials @NRGonc GI011. @lauren_henke
@TedHong9
@UTSWMedCenter
@utswcancer
@UTSW_RadOnc
@ASCO
Want to learn about the newest NRG trial in #pancreaticcancer - Our Podcast co-hosts sit with @NiuSanford to discuss the NRG-GI011 "LAP100" trial of dose escalated RT next week. Follow us where you get your podcasts at https://t.co/2vKAkmhCrN
@StephenChunMD @Lauren_Henke
2
8
32
Nobody other than @DrSpratticus could have done a better job on this...@PCF_Science
Truly honored to speak @PCF_Science in front of countless giants in the field to discuss the ongoing legacy of @felixfengmd and our practice changing results showing for the 1st time in history a prospectively validated predictive biomarker for hormone therapy in prostate cancer!
1
0
6
@ChapinMD @HimanshuNagarMD @AmarUKishan 4/n If WW in IR and AM in GG2 are not safe, then what about AS in GG2? Sunnybrook data shows that this still is not very safe with 15 year mets risk of 16% in their historical data published. Note that almost all mets events occur around or beyond 10 years. @DrAndrewLoblaw
1
3
5
Truly honored to speak @PCF_Science in front of countless giants in the field to discuss the ongoing legacy of @felixfengmd and our practice changing results showing for the 1st time in history a prospectively validated predictive biomarker for hormone therapy in prostate cancer!
@DrSpratticus giving the Felix Feng Legacy Lecture Felixโs impact on patients is mind boggling. And will continue for decades, at minimum Amazingly, his impact on team science and mentoring in #ProstateCancer may be even larger!
2
10
73
@DrSpratticus giving the Felix Feng Legacy Lecture Felixโs impact on patients is mind boggling. And will continue for decades, at minimum Amazingly, his impact on team science and mentoring in #ProstateCancer may be even larger!
1
21
67
0
1
7
๐จ *St Francis Heart Center, NY CardioOncology Journal Club* @Soum_Roy_RadOnc (@cwru) and @avirupguha (@avirupguha) joined us to discuss Statin ๐ assoc with โฌ๏ธ Overall Survival ๐ in Advanced Prostate Ca pts (TITAN and SPARTAN Trials) Watch: https://t.co/Pgkuy1nYBJ
#CardioOnc
1
4
12
The RAMPP trial has landed โผ๏ธ Congratulations to the authors for this great work!! It compared best systemic therapy + RP (with extended LND) to BST alone for patients with de-novo synchronous oligometastatic PCa, defined as =< 5 bone mets. BST consisted of lifelong ADT. It
7
21
47
Local therapy and outcome in de novo metastatic #ProstateCancer: Individual patient data analysis of the #TITAN and #ARASENS trials. Presentation by @Soum_Roy_RadOnc @caseccc. #ASTRO25 written coverage by @zklaassen_md @GACancerCenter > https://t.co/cfDIaVGLVf
@ASTRO_org
0
5
7
Our awesome PGY-5 @RohanPatelMD teaming up with @IBCradiation to share evidence-based strategies for wellness in #RadOnc โข๏ธ ๐โค๏ธโ๐ฉน #ASTRO25
0
6
18
#ASTRO25 Local Rx & Outcome in de novo mPCa: IPD Analysis of TITAN and ARASENS @urotoday @Soum_Roy_RadOnc ๐โฌ๏ธ OS w/ local Rx for pts on ADT (HR 0.69, 95% CI 0.47-1.00) and ADT + ARPI (HR 0.69, 95% CI 0.41-1.07) ๐vs no local Rx, RT assoc w/ โฌ๏ธ OS (HR 0.68, 95% CI 0.50-0.98)
2
10
16
Miss @DrSpratticus 's presentation on @NRGonc GU-006's practice changing results in the @astro_org Clinical Trials session tdoay? Get all the details and expanded discussion on our podcast episode here: ๐ https://t.co/BEvnek9Bx6 ๐ง: https://t.co/MUe3UKjTJJ
๐จ NRGGU006: prospectively validated ๐ฏ PAM50 = predictive ๐ฌ biomarker for ARPI in #ProstateCancer! Adding apalutamide ๐ to salvage RT (no ADT) boosted 5-yr bPFS (72% vs 54%) & MFS (95% vs 82%) in luminal B tumors โก๏ธ no benefit in others. @DrSpratticus
#ASTRO25 #RadOnc
1
15
45
Medical students interested in #radonc residency, don't forget to attend our happy hour meeting https://t.co/5rEMqM1xCb
๐จโญ๏ธAre you an MS4 or prospective resident going to #ASTRO25 in San Francisco? Come join our residency leadership and residents for Happy Hour on Sunday, Sept 28th from 3:30-4:30PM PST @ The Harlequin! Food & drinks provided! Sign up here๐๐ผ https://t.co/BpsNqJC4Sl
0
3
10
Our stellar team at @RadOncUH @UHhospitals @CWRUSOM @caseccc looks forward to the @ASTRO_org #ASTRO25 #radonc international meeting in San Francisco. This year, we have over 30 exciting presentations. We hope to see you there!
3
11
44
๐ฏ @RadOncUH our team will raise you up ๐ฆ#LionKing Come meet us at #ASTRO25 : https://t.co/sxdEQb0FsP
It is THE most happening meet and greet!!!
1
2
27
1
3
31
๐จโญ๏ธAre you an MS4 or prospective resident going to #ASTRO25 in San Francisco? Come join our residency leadership and residents for Happy Hour on Sunday, Sept 28th from 3:30-4:30PM PST @ The Harlequin! Food & drinks provided! Sign up here๐๐ผ https://t.co/BpsNqJC4Sl
1
14
23
The hardest lessons after training arenโt always in the OR or clinic. ๐ I wrote this essay for anyone navigating their first year as an attending. โUnseen Scarsโ in @JAMA_current ๐ https://t.co/0e09Zx1nb6
54
165
685